Variations in, and elevation of, serum glucose within 24 hours of isolated CABG were associated with a significantly increased risk of cardiovascular complications and mortality within 30 days.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Coronary disease
November 25, 2019
November 18, 2019
An editorial related to a recent randomized controlled trial suggesting a striking benefit of anti-inflammatory secondary prevention after recent myocardial events.
November 11, 2019
A useful narrative on pharmacology and metabolomics for surgeons caring for the diabetic population; the vast majority of the CTSNet membership.
November 6, 2019
In this randomized trial, percutaneous coronary intervention and CABG had equivalent outcomes for the composite of death, stroke, or myocardial infarction at five years for patients with left main disease of low or intermediate anatomical complexity.
November 1, 2019
In this multicenter study, the authors report on outcomes in 156 patients who underwent surgery for anomalous aortic origin of the coronary arteries. Unroofing and reimplantation were the most common procedures. There was no perioperative mortality.
October 29, 2019
This article reviews real-life outcomes of 42,714 patients undergoing coronary bypass grafting from 2005 to 2012.
October 26, 2019
Interesting clinicolaboratory experiment: Any translational value for the coronary surgeon and the cardiologist remains to be seen, especially regarding the risk stratification and prioritization for urgent (inpatient) revascularisation. Also, the value of the observation for the cardiovascular anesthetist may be important with regards to induction
October 20, 2019
In this video, the authors demonstrate off-pump coronary artery bypass with the bilateral internal thoracic artery for left main disease.
October 19, 2019
Quite interesting to see that the incidence of revascularisation after multivessel PCA (the additional element on the second co-primary outcome) appears to have occured in more than 1% of the patients within three years...
October 18, 2019
Using data from the FREEDOM (Future Revascularizaiton Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease) trial, the authors developed an 8 variable model that predicts individual risk of major acute cardiovascular events in diabetic patients with multivessel disease.